Answers are grounded in this paper and cite their sources.
Introduction The diagnostic accuracy of phenotype-matching tools for rare diseases depends not only on the algorithm but also on the quality of the disease definitions. Inherited kidney diseases (IKDs) pose a significant challenge for clinical diagnosis due to substantial phenotypic overlap and heterogeneity, yet many patients remain undiagnosed despite growing access to genetic testing. This study assesses whether an expert-curated, IKD-specific database (CURATED) provides a closer phenotypic match to real patients than the Mondo Disease Ontology (MONDO), a broad, general-purpose resource. Methods Using a cohort of 340 real-world patients with genetically confirmed diagnoses across eight IKD categories, we compared MONDO- and CURATED-based disease definitions across three independent, computational phenotype-matching tools (Phenomizer, Phrank, and Phen2Disease), which match HPO-annotated patient phenotypes to disease profiles, using similarity scoring, diagnostic ranking, and mixed-effects models accounting for disease imbalance and inter-annotator variability. Results With CURATED definitions, similarity scores rose by 18–30% and Discounted Cumulative Gain improved by 15–37% relative to MONDO, reflecting a stronger tendency across all three tools to place the correct diagnosis at or near the top of the ranked list. These improvements were maintained after mixed-effects modeling. Conclusion The quality of the underlying disease database can be as consequential as the choice of diagnostic algorithm. In this cohort, domain-specific curation improved diagnostic prioritization, suggesting that investment in high-quality, nephrology-specific phenotype resources may advance IKD diagnosis as much as further algorithmic refinement.
No takes yet. Share an insight, caveat, or question.
León et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: